✦ LIBER ✦

M1 Muscarinic Agonists Target Major Hallmarks of Alzheimer’s Disease – The Pivotal Role of Brain M1 Receptors

✍ Scribed by Fisher, Abraham

Book ID: 119984851
Publisher: S. Karger AG
Year: 2008
Tongue: English
Weight: 160 KB
Volume: 5
Category: Article
ISSN: 1660-2854
DOI: 10.1159/000113712

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

M1muscarinic agonists can modulate some

M1muscarinic agonists can modulate some of the hallmarks in Alzheimer’s disease

✍ Abraham Fisher; Zipora Pittel; Rachel Haring; Nira Bar-Ner; Michal Kliger-Spatz; 📂 Article 📅 2003 🏛 Humana Press Inc 🌐 English ⚖ 332 KB

Pharmacological Mechanisms in Alzheimer'

Pharmacological Mechanisms in Alzheimer's Therapeutics || M1 Muscarinic Agonists: A Comprehensive Therapy Against Major Hallmarks of Alzheimer's Disease

✍ Cuello, A. Claudio 📂 Article 📅 2007 🏛 Springer New York 🌐 English ⚖ 156 KB

The need for effective therapy to treat Alzheimer’s disease is greater than ever, but there is still no drug therapy that can stop or reverse the progression of the disease. There is, however, a great deal of anticipation over the imminent development of effective therapies as a result of the identi

Talsaclidine (WAL 2014 FU), a muscarinic

Talsaclidine (WAL 2014 FU), a muscarinic M1 receptor agonist for the treatment of Alzheimer's disease

✍ Marion Wienrich; Angelo Ceci; Helmut A. Ensinger; Wolfram Gaida; Klaus D. Mendla 📂 Article 📅 2002 🏛 John Wiley and Sons 🌐 English ⚖ 212 KB

Reduced High-Affinity Agonist Binding at

Reduced High-Affinity Agonist Binding at the M1 Muscarinic Receptor in Alzheimer's Disease Brain: Differential Sensitivity to Agonists and Divalent Cations

✍ Christopher J. Ladner; John M. Lee 📂 Article 📅 1999 🏛 Elsevier Science 🌐 English ⚖ 144 KB

SAT-5-2 The discovery and pharmacology o

SAT-5-2 The discovery and pharmacology of xanomeline, a muscarinic M1 receptor agonist for Alzheimer's disease

✍ H.E. Shannon; E.P. Bymaster; D.O. Calligaro; N.W. DeLapp; C.H. Mitch; J.S. Warc; 📂 Article 📅 1995 🏛 Elsevier Science 🌐 English ⚖ 138 KB

Novel m1 muscarinic agonists in treatmen

Novel m1 muscarinic agonists in treatment and delaying the progression of Alzheimer's disease: An unifying hypothesis

✍ Abraham Fisher; Rachel Brandeis; Rachel Haring; Naomi Eshhar; Eliahu Heldman; Yi 📂 Article 📅 1998 🏛 Elsevier Science 🌐 English ⚖ 366 KB

M1 Muscarinic Agonists Target Major Hallmarks of Alzheimer&rsquo;s Disease &ndash; The Pivotal Role of Brain M1 Receptors

M1 Muscarinic Agonists Target Major Hallmarks of Alzheimer’s Disease – The Pivotal Role of Brain M1 Receptors